Education
About Us
Working with TipRanks
Follow Us
As Partners CO.,LTD. (JP:160A)
:160A
RESEARCH TOOLSreports
Top Page
As Partners CO.,LTD.
(160A)
Rating:75Outperform
Price Target:
¥3,020.00
▲(11.03%Upside)
As Partners CO.,LTD. (160A) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥10.10B
Dividend Yield2.05%
Average Volume (3M)16.04K
Price to Earnings (P/E)10.5
Beta (1Y)0.76
Revenue GrowthN/A
EPS GrowthN/A
CountryJP
EmployeesN/A
SectorServices
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)13.90
Shares Outstanding3,580,400
10 Day Avg. Volume9,840
30 Day Avg. Volume16,036
Financial Highlights & Ratios
PEG Ratio-17.27
Price to Book (P/B)2.43
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥3,050.00Price Target Upside12.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
As Partners CO.,LTD. Business Overview & Revenue Model
Company Descriptionnull
How the Company Makes Moneynull
As Partners CO.,LTD. Financial Statement Overview
Summary
As Partners CO.,LTD. shows strong revenue and profitability growth, with improved cost management. However, increased leverage and negative free cash flow highlight potential risks, requiring focus on cash management and debt reduction.Income Statement
As Partners CO.,LTD. has demonstrated strong revenue growth with a 44.6% increase from 2023 to 2025. The gross profit margin improved from 16.8% in 2022 to 21.5% in 2025, indicating effective cost management. The net profit margin in 2025 is 5.3%, showing profitability improvements. EBIT and EBITDA margins have also increased, indicating operational efficiency. Overall, the income statement reflects robust growth and profitability.87
Very Positive
Balance Sheet
The company's debt-to-equity ratio increased from 3.05 in 2024 to 2.24 in 2025, suggesting higher leverage but still within manageable levels. Return on Equity (ROE) improved significantly to 22.97% in 2025, showcasing effective utilization of equity. However, the equity ratio is relatively low at 19.4%, indicating reliance on debt financing. The balance sheet shows strong equity growth but increased leverage, which could pose risks if not managed well.74
Positive
Cash Flow
Free cash flow turned negative in 2025, a concern given past positive figures. Operating cash flow to net income ratio decreased, indicating less cash generation relative to net income. The free cash flow to net income ratio also shows a decline. While the company is investing heavily, the negative free cash flow suggests potential liquidity concerns and reliance on external financing.68
Positive
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 17.92B | 17.15B | 12.78B | 11.52B |
| Gross Profit | 3.86B | 3.11B | 2.15B | 1.87B |
| EBITDA | 1.64B | 1.08B | 552.06M | 1.02B |
| Net Income | 956.66M | 563.57M | 229.71M | 484.94M |
Balance Sheet | ||||
| Total Assets | 21.41B | 15.95B | 14.74B | 11.81B |
| Cash, Cash Equivalents and Short-Term Investments | 6.86B | 5.71B | 4.02B | 3.86B |
| Total Debt | 9.31B | 5.66B | 6.49B | 5.13B |
| Total Liabilities | 17.24B | 13.57B | 12.88B | 10.13B |
| Stockholders Equity | 4.16B | 2.38B | 1.86B | 1.68B |
Cash Flow | ||||
| Free Cash Flow | -3.29B | 2.19B | -1.86B | -1.06B |
| Operating Cash Flow | 1.31B | 3.43B | -745.18M | -338.97M |
| Investing Cash Flow | -4.65B | -1.43B | -707.64M | 928.45M |
| Financing Cash Flow | 4.46B | -884.25M | 1.31B | -369.06M |
As Partners CO.,LTD. Technical Analysis
Positive
2720.00
Price Trends
2506.92
Positive
2208.69
Positive
1993.54
Positive
Market Momentum
45.16
Positive
55.99
Neutral
24.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:160A, the sentiment is Positive. The current price of 2720 is above the 20-day moving average (MA) of 2649.10, above the 50-day MA of 2506.92, and above the 200-day MA of 1993.54, indicating a bullish trend. The MACD of 45.16 indicates Positive momentum. The RSI at 55.99 is Neutral, neither overbought nor oversold. The STOCH value of 24.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:160A.
As Partners CO.,LTD. Peers Comparison
Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥3.10B | 8.30 | 2.46% | 2.33% | -0.96% | ||
75 Outperform | ¥10.10B | 10.45 | 2.05% | ― | ― | ||
72 Outperform | ¥11.26B | 15.30 | 1.31% | 20.50% | 62.39% | ||
67 Neutral | ¥9.10B | 25.67 | ― | 10.60% | 15.70% | ||
65 Neutral | CHF7.22B | 5.49 | 13.90% | 2.95% | -1.36% | 0.37% | |
64 Neutral | ¥5.68B | 7.97 | 4.02% | 8.95% | ― | ||
63 Neutral | ¥8.87B | 16.02 | 1.44% | 21.97% | -20.94% |
* Services Sector Average
Performance Comparison
JP:160A
As Partners CO.,LTD.
2,820.00
1,264.18
81.25%
JP:2373
Care Twentyone Corporation
422.00
8.98
2.17%
JP:2425
Care Service Co., Ltd.
818.00
79.18
10.72%
JP:6557
AIAI Group Corporation
1,370.00
200.00
17.09%
JP:7061
Japan Hospice Holdings Inc.
1,052.00
90.56
9.42%
JP:7133
HYUGA PRIMARY CARE Co.,Ltd.
1,547.00
383.71
32.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.